Literature DB >> 23463263

Nano-extrusion: a one-step process for manufacturing of solid nanoparticle formulations directly from the liquid phase.

Johannes Khinast1, Ramona Baumgartner, Eva Roblegg.   

Abstract

This paper presents a novel one-step process for converting a liquid stabilized nano-suspension into a solid formulation via hot-melt extrusion combined with an internal devolatilization process (nano-extrusion, NANEX). A polymer (Soluplus®) was fed into the extruder and molten, after which a stable nano-suspension was added via side-feeding devices. The solvent (water) was removed by devolatilization and the polymer solidified at the outlet. The solid material can be tableted or filled in a capsule directly. The results showed that the obtained extrudates comprised nanocrystals in the de-aggregated form, confirming that a solid nano-formulation was prepared. This method is capable of overcoming many of the problems associated with other processes involving solid nano-dosage forms and poses a straightforward approach towards manufacturing such products.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23463263      PMCID: PMC3665983          DOI: 10.1208/s12249-013-9946-0

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  13 in total

1.  Production and characterisation of highly concentrated nanosuspensions by high pressure homogenisation.

Authors:  K P Krause; R H Müller
Journal:  Int J Pharm       Date:  2001-02-19       Impact factor: 5.875

Review 2.  Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

Authors:  R H Müller; C Jacobs; O Kayser
Journal:  Adv Drug Deliv Rev       Date:  2001-03-23       Impact factor: 15.470

3.  Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution.

Authors:  Xiaoxia Chen; Timothy J Young; Marazban Sarkari; Robert O Williams; Keith P Johnston
Journal:  Int J Pharm       Date:  2002-08-21       Impact factor: 5.875

4.  Enhanced drug dissolution using evaporative precipitation into aqueous solution.

Authors:  Marazban Sarkari; Judith Brown; Xiaoxia Chen; Steve Swinnea; Robert O Williams; Keith P Johnston
Journal:  Int J Pharm       Date:  2002-08-28       Impact factor: 5.875

5.  A new methodology for studying nanoparticle interactions in biological systems: dispersing titania in biocompatible media using chemical stabilisers.

Authors:  Sonia Ramirez-Garcia; Lan Chen; Michael A Morris; Kenneth A Dawson
Journal:  Nanoscale       Date:  2011-09-30       Impact factor: 7.790

Review 6.  Drugs as materials: valuing physical form in drug discovery.

Authors:  Colin R Gardner; Christopher T Walsh; Orn Almarsson
Journal:  Nat Rev Drug Discov       Date:  2004-11       Impact factor: 84.694

Review 7.  Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products.

Authors:  Bernard Van Eerdenbrugh; Guy Van den Mooter; Patrick Augustijns
Journal:  Int J Pharm       Date:  2008-07-31       Impact factor: 5.875

Review 8.  Innovative strategies for the oral delivery of drugs and peptides.

Authors:  A Fasano
Journal:  Trends Biotechnol       Date:  1998-04       Impact factor: 19.536

9.  Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985).

Authors:  R A Prentis; Y Lis; S R Walker
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

Review 10.  The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs.

Authors:  J E Kipp
Journal:  Int J Pharm       Date:  2004-10-13       Impact factor: 5.875

View more
  12 in total

Review 1.  Nanomedicine scale-up technologies: feasibilities and challenges.

Authors:  Rishi Paliwal; R Jayachandra Babu; Srinath Palakurthi
Journal:  AAPS PharmSciTech       Date:  2014-07-22       Impact factor: 3.246

Review 2.  Bioavailability Enhancement of Poorly Water-Soluble Drugs via Nanocomposites: Formulation⁻Processing Aspects and Challenges.

Authors:  Anagha Bhakay; Mahbubur Rahman; Rajesh N Dave; Ecevit Bilgili
Journal:  Pharmaceutics       Date:  2018-07-08       Impact factor: 6.321

3.  Soluplus micelles for improving the oral bioavailability of scopoletin and their hypouricemic effect in vivo.

Authors:  Ying-Chun Zeng; Sha Li; Chang Liu; Tao Gong; Xun Sun; Yao Fu; Zhi-Rong Zhang
Journal:  Acta Pharmacol Sin       Date:  2017-01-23       Impact factor: 6.150

4.  Development of an Abuse- and Alcohol-Resistant Formulation Based on Hot-Melt Extrusion and Film Coating.

Authors:  Nicole Jedinger; Simone Schrank; Johannes M Fischer; Karlheinz Breinhälter; Johannes Khinast; Eva Roblegg
Journal:  AAPS PharmSciTech       Date:  2015-07-24       Impact factor: 3.246

5.  Manufacturing strategies to develop amorphous solid dispersions: An overview.

Authors:  Nicole Mendonsa; Bjad Almutairy; Venkata Raman Kallakunta; Sandeep Sarabu; Priyanka Thipsay; Suresh Bandari; Michael A Repka
Journal:  J Drug Deliv Sci Technol       Date:  2019-12-11       Impact factor: 3.981

Review 6.  Melt extrusion with poorly soluble drugs - An integrated review.

Authors:  Michael A Repka; Suresh Bandari; Venkata Raman Kallakunta; Anh Q Vo; Haley McFall; Manjeet B Pimparade; Ajinkya M Bhagurkar
Journal:  Int J Pharm       Date:  2017-11-02       Impact factor: 5.875

7.  Revealing Polymorphic Phase Transformations in Polymer-Based Hot Melt Extrusion Processes.

Authors:  José R Hernández Espinell; Vilmalí López-Mejías; Torsten Stelzer
Journal:  Cryst Growth Des       Date:  2018-03-09       Impact factor: 4.076

8.  One Polymorph and Various Morphologies of Phenytoin at a Silica Surface Due to Preparation Kinetics.

Authors:  Heike M A Ehmann; Ramona Baumgartner; Daniela Reischl; Eva Roblegg; Andreas Zimmer; Roland Resel; Oliver Werzer
Journal:  Cryst Growth Des       Date:  2014-11-25       Impact factor: 4.076

9.  Towards predicting the product quality in hot-melt extrusion: Pilot plant scale extrusion.

Authors:  Josip Matić; Carolina Alva; Simone Eder; Kathrin Reusch; Amrit Paudel; Johannes Khinast
Journal:  Int J Pharm X       Date:  2021-06-06

10.  Surface-Induced Polymorphism as a Tool for Enhanced Dissolution: The Example of Phenytoin.

Authors:  Daniela Reischl; Christian Röthel; Paul Christian; Eva Roblegg; Heike M A Ehmann; Ingo Salzmann; Oliver Werzer
Journal:  Cryst Growth Des       Date:  2015-08-10       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.